1. Home
  2. ACET vs GROV Comparison

ACET vs GROV Comparison

Compare ACET & GROV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Adicet Bio Inc.

ACET

Adicet Bio Inc.

HOLD

Current Price

$0.50

Market Cap

93.5M

Sector

Health Care

ML Signal

HOLD

Logo Grove Collaborative Holdings Inc.

GROV

Grove Collaborative Holdings Inc.

HOLD

Current Price

$1.32

Market Cap

55.0M

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACET
GROV
Founded
1947
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Package Goods/Cosmetics
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
93.5M
55.0M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ACET
GROV
Price
$0.50
$1.32
Analyst Decision
Buy
Buy
Analyst Count
4
2
Target Price
$8.50
$1.60
AVG Volume (30 Days)
2.1M
69.1K
Earning Date
11-05-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$180,808,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$16.02
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.45
$1.02
52 Week High
$1.11
$1.95

Technical Indicators

Market Signals
Indicator
ACET
GROV
Relative Strength Index (RSI) 33.24 44.48
Support Level $0.50 $1.22
Resistance Level $0.59 $1.39
Average True Range (ATR) 0.05 0.06
MACD 0.00 -0.00
Stochastic Oscillator 2.33 45.95

Price Performance

Historical Comparison
ACET
GROV

About ACET Adicet Bio Inc.

Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Its product candidate, ADI-001, a first-in-class allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, is being developed for the potential treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma. Their pipeline also includes its preclinical candidate, ADI-270, an armored gamma delta CAR T cell product candidate targeting renal cell carcinoma, with potential for other CD70+ solid tumor and hematological malignancies indications.

About GROV Grove Collaborative Holdings Inc.

Grove Collaborative Holdings Inc is engaged in providing consumer products. It offers Cleaning accessories, Home and Pantry, Personal care products, Pets supplements and Other products. It is a sustainability oriented consumer products generator. It use connection with consumers to create and curate authentic, disruptive brands and products. Company builds natural products that perform as well as, many consumer packaged goods (CPG) brands (both conventional and natural), while being healthier for consumers and the planet.

Share on Social Networks: